Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
1. 系统已在2026-04-21 14:04:07对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S1473-3099(24)00499-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1473309924004997
其他信息:
出版社: Elsevier BV
作者: Yehuda Carmeli; José Miguel Cisneros; Mical Paul; George L Daikos; Minggui Wang; Julian Torre-Cisneros; George Singer; Ivan Titov; Illia Gumenchuk; Yongjie Zhao; Rosa-María Jiménez-Rodríguez; Lu Liang; Gang Chen; Oleksandr Pyptiuk; Firdevs Aksoy; Halley Rogers; Michele Wible; Francis F Arhin; Alison Luckey; Joanne L Leaney; Rienk Pypstra; Joseph W Chow; Marc Bonten; Jesús Rodríguez-Baño; Christine Lammens; Herman Goossens; Surbhi Malhotra-Kumar
